Welcome to Paid Research Studies




  • Condition:   Cranial Nerve Diseases
    Intervention:   Other: Group Isolated
    Sponsor:   Diskapi Yildirim Beyazit Education and Research Hospital
    Recruiting

  • Condition:   Cranial Nerve Palsy
    Intervention:   Procedure: preoperative cerebral MRI and operative findings
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Conditions:   Central Nervous System Neoplasm;   Cranial Nerve Disorder;   Loss of Consciousness;   Paresis
    Interventions:   Drug: Ferumoxytol;   Drug: Gadolinium;   Procedure: Magnetic Resonance Imaging
    Sponsors:   OHSU Knight Cancer Institute;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Optic Nerve Disorders
    Intervention:  
    Sponsor:   University of Colorado, Denver
    Recruiting

  • Condition:   Neuropathy, Optic
    Intervention:  
    Sponsor:   Poitiers University Hospital
    Recruiting

  • Condition:   Optic Neuropathy
    Intervention:   Device: magnetic resonance image (MRI)
    Sponsor:   University of Miami
    Recruiting

  • Condition:   Optic Neuropathy
    Intervention:   Biological: Stem Cells
    Sponsor:   Stem Cells Arabia
    Recruiting

  • Conditions:   Concussion;   Convergence Insufficiency
    Interventions:   Behavioral: Standard Community Concussion Care (SC);   Behavioral: SC plus Simple Convergence Procedures (SC+);   Behavioral: SC plus Office-based Vergence/Accommodative Therapy (SC+VAT)
    Sponsors:   Mitchell Scheiman;   Ohio State University;   University of Alabama at Birmingham;   Marshall B. Ketchum University;   Stanford University;   Children's Hospital Medical Center, Cincinnati;   Children's Hospital of Philadelphia;   Boston Children’s Hospital;   New Jersey Institute of Technology
    Not yet recruiting

  • Condition:   Strabismus
    Intervention:  
    Sponsors:   Royal Liverpool and Broadgreen University Hospitals NHS Trust;   Manchester University NHS Foundation Trust
    Recruiting

  • Condition:   Convergence Insufficiency
    Intervention:   Behavioral: Office Based Vergence and Accommodative Therapy
    Sponsors:   New Jersey Institute of Technology;   National Eye Institute (NEI)
    Recruiting

  • Condition:   Optokinetic Nystagmus
    Intervention:   Device: CAVA
    Sponsors:   Emily Woodhouse;   University of East Anglia;   Medical Research Council
    Recruiting

  • Condition:   Strabismus
    Intervention:   Other: Evaluate the reliability and reproductibility of the automated angular measurement by the Gazelab
    Sponsor:   Nantes University Hospital
    Not yet recruiting

  • Condition:   Horizontal Strabismus With High AC/A Ratio
    Interventions:   Procedure: conducting the slanted recession technique on the superior and inferior poles;   Procedure: conducting the augmented recession technique on the muscle
    Sponsor:   Shahid Beheshti University of Medical Sciences
    Recruiting

  • Condition:   Strabismus
    Interventions:   Procedure: Symmetrical IO weakening;   Procedure: Asymmetrical IO weakening
    Sponsors:   Sultan Qaboos University;   Christian Medical College, Vellore, India
    Recruiting

  • Condition:   Convergence Insufficiency
    Intervention:   Procedure: office-based vergence/accommodative therapy
    Sponsor:   Salus University
    Recruiting

  • Condition:   Acquired Esotropia
    Interventions:   Drug: Botulinum toxin type A;   Procedure: Strabismus surgery
    Sponsor:   University Hospital Inselspital, Berne
    Recruiting

  • Condition:   Strabismus
    Intervention:   Other: EyeTurn App
    Sponsors:   Massachusetts Eye and Ear Infirmary;   National Eye Institute (NEI)
    Recruiting

  • Conditions:   Anxiety;   Strabismus;   Compliance
    Intervention:  
    Sponsors:   Queen's University;   University of Regina
    Recruiting

  • Condition:   Exotropia
    Interventions:   Procedure: Plication strabismus surgery;   Procedure: Resection strabismus surgery
    Sponsor:   Shahid Beheshti University of Medical Sciences
    Not yet recruiting

  • Condition:   Intermittent Exotropia
    Intervention:   Other: patch therapy
    Sponsor:   Tehran University of Medical Sciences
    Not yet recruiting

  • Condition:   Intermittent Exotropia
    Intervention:   Device: Controlled Intermittent Alternate Occlusion (CIAO ) glasses
    Sponsor:   Salus University
    Recruiting

  • Condition:   Moderate Intermittent Exotropia
    Intervention:   Procedure: recession or resection of the horizontal extraocular muscles
    Sponsor:   Sun Yat-sen University
    Recruiting

  • Conditions:   Encephalitis;   Myelitis;   Guillain-Barre Syndrome;   Cranial Nerve Palsies;   Meningitis;   Zika Virus Infection;   Dengue (Virus); Fever, Sandfly;   Chikungunya Fever
    Intervention:  
    Sponsors:   Johns Hopkins University;   Universidad del Valle, Colombia;   ZikaPLAN
    Recruiting

  • Condition:   Ischemic Optic Neuropathy
    Interventions:   Drug: Alprostadil 20 micrograms;   Drug: Placebo
    Sponsor:   Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
    Recruiting

  • Condition:   Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
    Interventions:   Drug: Oral prednisolone administration 50 mg;   Drug: Intravenous Erythropoietin injection
    Sponsor:   Shahid Beheshti University of Medical Sciences
    Recruiting

  • Condition:   Nonarteritic Anterior Ischemic Optic Neuropathy
    Interventions:   Drug: RPh201;   Other: Placebo
    Sponsor:   Regenera Pharma Ltd
    Recruiting

  • Condition:   Anterior Ischemic Optic Neuropathy
    Interventions:   Device: Dynamic Vessel Analyzer (DVA);   Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT);   Device: Optical coherence tomography (OCT)
    Sponsor:   Medical University of Vienna
    Recruiting

  • Condition:   Ischemic Optic Neuropathy
    Interventions:   Drug: bosentan;   Drug: placebo
    Sponsor:   University Hospital, Grenoble
    Recruiting

  • Condition:   Non Arteritic Anterior Ischemic Optic Neuropathy
    Interventions:   Drug: QPI-1007 Injection - 1.5 mg;   Drug: QPI-1007 Injection - 3.0 mg;   Other: Sham Injection Procedure
    Sponsor:   Quark Pharmaceuticals
    Recruiting

  • Condition:   Acute Autoimmune Inflammatory Optic Neuritis
    Interventions:   Device: active-rtACS treatment;   Device: sham-rtACS treatment
    Sponsors:   University of Zurich;   University Hospital, Zürich;   Swiss MS Society;   Data Management, Clinical Trials Center, Zurich, Switzerland
    Not yet recruiting

  • Condition:   Optic Neuritis
    Intervention:  
    Sponsor:   University Hospital, Lille
    Recruiting

  • Condition:   Optic Neuritis
    Interventions:   Device: Corticosteroid & Plasma exchange;   Drug: Corticosteroid
    Sponsor:   Chinese PLA General Hospital
    Recruiting

  • Condition:   Optic Neuritis
    Intervention:   Device: MRI
    Sponsor:   Rennes University Hospital
    Recruiting

  • Condition:   Optic Neuritis
    Interventions:   Drug: Vitamin D3;   Drug: Placebo/Standard of Care Vitamin D3
    Sponsor:   University of Calgary
    Recruiting

  • Condition:   Optic Papilla Edema
    Intervention:   Diagnostic Test: Ultrasonic Measurement will be taken from optic nerve sheat diameter and compared-classified.
    Sponsor:   Cukurova University
    Recruiting

  • Condition:   Optic Neuritis
    Interventions:   Drug: Clemastine;   Drug: Placebo
    Sponsors:   University of California, San Francisco;   Moorfields Eye Hospital NHS Foundation Trust
    Recruiting

  • Conditions:   Neuromyelitis Optica Spectrum Disorders;   Neuromyelitis Optica Spectrum Related Disorders
    Intervention:  
    Sponsor:   Hospices Civils de Lyon
    Recruiting

  • Conditions:   Parkinson's Disease;   Parkinsonian Disorders;   Atypical Parkinson Disease;   Progressive Supranuclear Palsy;   Multiple System Atrophy;   Corticobasal Degeneration;   Gait, Frontal
    Interventions:   Drug: Anti-Parkinson medication;   Device: Deep Brain Stimulation
    Sponsor:   Beth Israel Deaconess Medical Center
    Recruiting

  • Condition:   Leber Hereditary Optic Neuropathy
    Intervention:   Other: Patient-reported outcomes (PROs)
    Sponsor:   GenSight Biologics
    Recruiting

  • Condition:   Leber Hereditary Optic Neuropathy
    Interventions:   Genetic: GS010;   Drug: Placebo
    Sponsor:   GenSight Biologics
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Meniere Disease
    Intervention:   Device: Cochlear Implant
    Sponsors:   Ohio State University;   Advanced Bionics
    Recruiting

  • Condition:   Leber's Hereditary Optic Neuropathy (LHON)
    Intervention:   Drug: Idebenone
    Sponsor:   Santhera Pharmaceuticals
    Recruiting

  • Condition:   Neuromyelitis Optica Spectrum Disorder
    Interventions:   Diagnostic Test: serum aquaporin 4 antibody (AQP-4-Ab);   Diagnostic Test: serum MOG antibody (anti-MOG);   Diagnostic Test: MRI brain, spine and orbit
    Sponsor:   Assiut University
    Not yet recruiting

  • Condition:   Trigeminal Neuropathy, Traumatic
    Interventions:   Drug: BOTOX®, Allergan;   Drug: Placebo
    Sponsors:   Assistance Publique - Hôpitaux de Paris;   Karolinska Institutet;   University of Aarhus
    Not yet recruiting

  • Condition:   Leber's Hereditary Optic Neuropathy
    Interventions:   Drug: injection of scAAV2-P1ND4v2 5.00x10e9 vg (Low),;   Drug: injection of scAAV2-P1ND4v2 2.46X10e10 vg (Med);   Drug: injection of scAAV2-P1ND4v2 1.0X10e11vg (High)
    Sponsors:   John Guy;   National Eye Institute (NEI)
    Recruiting

  • Conditions:   Neuromyelitis Optica;   Devic's Disease;   NMO Spectrum Disorder
    Interventions:   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Mesna;   Drug: rATG;   Drug: Methylprednisolone;   Drug: G-CSF;   Biological: IVIg;   Biological: Autologous Stem Cells
    Sponsor:   Northwestern University
    Recruiting

  • Conditions:   Spinal Cord Disease;   Intracranial Central Nervous System Disorder;   Neurologic Disorders;   Brain Neoplasms
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Condition:   Traumatic Optic Neuropathy
    Intervention:   Drug: Recombinant human erythropoietin
    Sponsors:   Iran University of Medical Sciences;   Mashhad University of Medical Sciences;   Shiraz University of Medical Sciences;   Tabriz University of Medical Sciences;   Tehran University of Medical Sciences
    Recruiting

  • Condition:   Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
    Intervention:   Genetic: GS010
    Sponsor:   GenSight Biologics
    Available

  • Conditions:   Facial Palsy;   Facial Nerve Diseases;   Borrelia Infection of Central Nervous System;   Bell Palsy
    Interventions:   Drug: Prednisolone;   Drug: Placebo Oral Tablet
    Sponsors:   Dalarna County Council, Sweden;   Karolinska Institutet
    Not yet recruiting

  • Condition:   Neuromyelitis Optica Spectrum Disorders
    Interventions:   Biological: Placebo;   Biological: RC18 160 mg
    Sponsor:   RemeGen
    Recruiting

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia;   Multiple Endocrine Neoplasia;   Multiple Endocrine Neoplasia Type II;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Multiple Endocrine Neoplasia, Type IV;   Multiple Endocrine Neoplasia, Type 3;   Multiple Endocrine Neoplasia (MEN) Syndrome;   Multiple Endocrine Neoplasia Type 2B;   Multiple Endocrine Neoplasia Type 2A;   Atypical Hemolytic Uremic Syndrome;   Atypical HUS;   Wiedemann-Steiner Syndrome;   Breast Implant-Associated Anaplastic Large Cell Lymphoma;   Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA);   Hemophagocytic Lymphohistiocytosis;   Behcet's Disease;   Alagille Syndrome;   Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD);   Lowe Syndrome;   Pitt Hopkins Syndrome;   1p36 Deletion Syndrome;   Jansen Type Metaphyseal Chondrodysplasia;   Cockayne Syndrome;   Chronic Recurrent Multifocal Osteomyelitis;   CRMO;   Malan Syndrome;   Hereditary Sensory and Autonomic Neuropathy Type Ie
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV (ML4) Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated;   American Multiple Endocrine Neoplasia Support;   Atypical Hemolytic Uremic Syndrome Foundation;   All Things Kabuki;   Wiedemann-Steiner Syndrome Foundation;   Breast Implant Victim Advocates;   PROS Foundation;   American Behcet's Disease Association
    Recruiting

  • Conditions:   Parkinson Disease;   Parkinsonism;   Lewy Body Disease;   Supranuclear Palsy, Progressive;   Parkinsonism Vascular;   Multiple System Atrophy;   Corticobasal Degeneration
    Intervention:   Behavioral: Palliative Care
    Sponsors:   University of Colorado, Denver;   National Institute of Nursing Research (NINR);   University of California, San Francisco
    Recruiting

  • Conditions:   Healthy Volunteers;   Alzheimer Disease;   Progressive Supranuclear Palsy
    Intervention:   Drug: [18F]MNI-958
    Sponsor:   Invicro
    Recruiting

  • Conditions:   Progressive Supranuclear Palsy;   Dementia With Lewy Bodies;   Multiple System Atrophy;   Corticobasal Syndrome;   Atypical Parkinson Disease
    Interventions:   Behavioral: Home Visit Program;   Behavioral: Usual Care/Online Survey
    Sponsor:   Rush University Medical Center
    Recruiting

  • Condition:   Neuromyelitis Optica Spectrum Disorder
    Intervention:   Biological: Corticosteroids & tanCART19/20
    Sponsor:   Chinese PLA General Hospital
    Not yet recruiting

  • Conditions:   Brain Disorders;   Birth Defects;   Craniofacial Differences
    Intervention:  
    Sponsors:   National Human Genome Research Institute (NHGRI);   National Eye Institute (NEI);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Icahn School of Medicine at Mount Sinai;   Boston Children’s Hospital
    Recruiting

  • Conditions:   Retinal Disease;   Age-Related Macular Degeneration;   Retinitis Pigmentosa;   Stargardt Disease;   Optic Neuropathy;   Nonarteritic Ischemic Optic Neuropathy;   Optic Atrophy;   Optic Nerve Disease;   Glaucoma;   Leber Hereditary Optic Neuropathy;   Blindness;   Vision Loss Night;   Vision Loss Partial;   Vision, Low;   Retinopathy;   Maculopathy;   Macular Degeneration;   Retina Atrophy
    Interventions:   Procedure: Arm 1;   Procedure: Arm 2;   Procedure: Arm 3
    Sponsor:   MD Stem Cells
    Recruiting

  • Conditions:   Neurologic Disorders;   Nervous System Diseases;   Neurodegenerative Diseases;   Neurological Disorders;   Stroke;   Traumatic Brain Injury;   Cadasil;   Chronic Traumatic Encephalopathy;   Cerebral Infarction;   Cerebral Ischemia;   Cerebral Stroke;   Cerebral Hemorrhage;   Parkinson;   Multi-System Degeneration;   MSA - Multiple System Atrophy;   Progressive Supranuclear Palsy;   ALS;   Amyotrophic Lateral Sclerosis;   Neuropathy;   Diabetic Neuropathies
    Interventions:   Procedure: Intravenous BMSC;   Procedure: Intranasal BMSC
    Sponsors:   MD Stem Cells;   The Healing Institute
    Recruiting

  • Conditions:   Frontotemporal Lobar Degeneration;   Amytrophic Lateral Sclerosis;   Progressive Supranuclear Palsy
    Intervention:  
    Sponsor:   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

  • Conditions:   Neuromyelitis Optica;   NMO Spectrum Disorder
    Intervention:  
    Sponsors:   Mayo Clinic;   Alexion Pharmaceuticals
    Recruiting

  • Conditions:   Advanced Malignant Neoplasm;   Castleman Disease;   Digestive System Carcinoma;   Erdheim-Chester Disease;   Lip and Oral Cavity Carcinoma;   Lymphangioleiomyomatosis;   Malignant Endocrine Neoplasm;   Malignant Female Reproductive System Neoplasm;   Malignant Male Reproductive System Neoplasm;   Malignant Neoplasm;   Malignant Respiratory Tract Neoplasm;   Malignant Thoracic Neoplasm;   Malignant Urinary System Neoplasm;   Mesothelial Neoplasm;   Metastatic Malignant Neoplasm;   Metastatic Urothelial Carcinoma;   Neurofibromatosis Type 2;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Breast Carcinoma;   Recurrent Childhood Soft Tissue Sarcoma;   Recurrent Digestive System Carcinoma;   Recurrent Female Reproductive System Carcinoma;   Recurrent Male Reproductive System Carcinoma;   Recurrent Malignant Neoplasm;   Recurrent Pharyngeal Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Refractory Malignant Neoplasm;   Soft Tissue Neoplasm;   Stage III Breast Cancer AJCC v7;   Stage III Pharyngeal Cancer;   Stage IIIA Breast Cancer AJCC v7;   Stage IIIB Breast Cancer AJCC v7;   Stage IIIC Breast Cancer AJCC v7;   Stage IV Breast Cancer AJCC v6 and v7;   Stage IV Pharyngeal Cancer;   Stage IVA Pharyngeal Cancer;   Stage IVB Pharyngeal Cancer;   Stage IVC Pharyngeal Cancer;   Thyroid Gland Neoplasm
    Interventions:   Biological: Bevacizumab;   Biological: Cetuximab;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Temsirolimus;   Drug: Valproic Acid
    Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Neuromyelitis Optica;   Neuromyelitis Optica Spectrum Disorder;   Transverse Myelitis;   Optic Neuritis
    Intervention:  
    Sponsor:   University of Texas Southwestern Medical Center
    Recruiting

  • Conditions:   Eye Diseases Hereditary;   Retinal Disease;   Achromatopsia;   Bardet-Biedl Syndrome;   Bassen-Kornzweig Syndrome;   Batten Disease;   Best Disease;   Choroidal Dystrophy;   Choroideremia;   Cone Dystrophy;   Cone-Rod Dystrophy;   Congenital Stationary Night Blindness;   Enhanced S-Cone Syndrome;   Fundus Albipunctatus;   Goldmann-Favre Syndrome;   Gyrate Atrophy;   Juvenile Macular Degeneration;   Kearns-Sayre Syndrome;   Leber Congenital Amaurosis;   Refsum Syndrome;   Retinitis Pigmentosa;   Retinitis Punctata Albescens;   Retinoschisis;   Rod-Cone Dystrophy;   Rod Dystrophy;   Rod Monochromacy;   Stargardt Disease;   Usher Syndrome
    Intervention:  
    Sponsor:   Foundation Fighting Blindness
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: Lidocaine;   Drug: Guanfacine
    Sponsor:   Vanderbilt University Medical Center
    Not yet recruiting

  • Conditions:   Alzheimer Disease (AD);   Frontotemporal Lobar Degeneration;   Dementia With Lewy Bodies (DLB);   Parkinson Disease Dementia (PDD);   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD)
    Intervention:  
    Sponsors:   Amoneta Diagnostics SAS;   European Commission;   Firalis SA;   University Hospital, Strasbourg;   Centre Hospitalier Universitaire Vaudois;   IRCCS Centro San Giovanni di Dio Fatebenefratelli;   Hôpitaux Civils de Colmar;   Istanbul University;   Assistance Publique - Hôpitaux de Paris;   University Hospital, Lille;   University Hospital, Geneva;   Cliniques universitaires Saint-Luc- Université Catholique de Louvain;   Erasme University Hospital;   University Hospital, Montpellier;   Centre Hospitalier Universitaire de Besancon;   Centre Hospitalier Universitaire de Nice
    Recruiting

  • Condition:   Non Arteritic Ischemic Optic Neuropathy
    Intervention:   Procedure: intravitreal injection of MSV
    Sponsors:   Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA;   University of Valladolid
    Recruiting

  • Condition:   Ophthalmoplegia
    Intervention:   Device: 3D PD T1 MRI sequence
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Recruiting

  • Condition:   Facial Neuritis
    Intervention:  
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting

  • Condition:   Ophthalmoplegia
    Intervention:   Diagnostic Test: MRI T2 sequence of the oculomotor tract
    Sponsor:   Fondation Ophtalmologique Adolphe de Rothschild
    Recruiting

  • Conditions:   Parkinson Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
    Intervention:  
    Sponsor:   University of Texas Southwestern Medical Center
    Not yet recruiting

  • Conditions:   Concussion, Mild;   Convergence Insufficiency;   Accommodation; Insufficiency
    Intervention:   Device: Glasses
    Sponsor:   University of Alabama at Birmingham
    Recruiting

  • Conditions:   Sclerosis, Multiple;   Neuromyelitis Optica Spectrum Disorder;   Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders;   Pregnancy Abnormal
    Intervention:   Other: No intervention
    Sponsor:   Hospices Civils de Lyon
    Not yet recruiting

  • Conditions:   Surgery;   Brain Tumor;   Brain Tumor, Recurrent;   Brain Pathology;   Spinal Diseases;   Spinal Stenosis;   Spinal Fusion;   Trigeminal Neuralgia;   Hydrocephalus;   Fusion of Spine;   Aneurysm;   SPINAL Fracture;   Chiari; Net;   Skull Injuries;   Brain Cancer;   Brain Metastases;   Brain Diseases;   Brain Lesion;   Brain Cyst;   Spinal Curvature;   Spinal Instability;   Spinal Cord Neoplasms
    Intervention:   Other: Transitional Care Programme
    Sponsors:   Barts & The London NHS Trust;   Brigham and Women's Hospital;   Harvard Medical School
    Recruiting

  • Conditions:   Ischemic Optic Neuropathy;   Branch Retinal Artery Occlusion;   Hemianopia;   Leber Hereditary Optic Neuropathy;   Acute Zonal Occult Outer Retinopathy
    Intervention:   Device: LSFG-NAVI
    Sponsor:   Randy Kardon
    Recruiting

  • Conditions:   Alzheimer Disease;   Alzheimer Dementia;   Vascular Dementia;   Lewy Body Disease;   Lewy Body Dementia With Behavioral Disturbance (Disorder);   Dementia, Mixed;   Parkinson-Dementia Syndrome;   Chronic Traumatic Encephalopathy;   Huntington's Dementia;   Wernicke Korsakoff Syndrome;   Traumatic Brain Injury;   Dementia, Multi-Infarct;   Autism;   Autism Spectrum Disorder;   Autistic Behavior;   Autistic Disorder, Current or Active State;   Cadasil
    Interventions:   Procedure: Intravenous Bone Marrow Stem Cell (BMSC) Fraction;   Procedure: Intranasal Topical Bone Marrow Stem Cell (BMSC) Fraction;   Procedure: Near Infrared Light
    Sponsor:   MD Stem Cells
    Recruiting

  • Conditions:   Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
    Intervention:  
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Conditions:   Pituitary Tumor;   Surgery;   Olfactory Nerve Injuries
    Intervention:   Procedure: Electrocautery versus scalpel
    Sponsor:   St. Michael's Hospital, Toronto
    Recruiting

  • Conditions:   FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
    Intervention:  
    Sponsors:   University of California, San Francisco;   National Center for Advancing Translational Science (NCATS);   National Institute of Neurological Disorders and Stroke (NINDS);   The Bluefield Project;   Tau Consortium
    Recruiting

  • Conditions:   Parkinsonian Syndromes;   Parkinson's Disease;   Multiple System Atrophy;   Progressive Supranuclear Palsy
    Interventions:   Other: CSF, blood and urine sampling;   Other: clinical measures of disease severity and progression
    Sponsor:   University Hospital, Bordeaux
    Recruiting

  • Conditions:   Thyroid Cancer;   Recurrent Laryngeal Nerve Injuries
    Intervention:   Procedure: Reversed Tracking Method
    Sponsor:   Fujian Medical University
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Visual Impairment;   Vestibular Meniere Syndrome
    Intervention:   Diagnostic Test: orthoptic balance
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Recruiting

  • Conditions:   Relapsing Remitting Multiple Sclerosis;   Optic Neuropathy;   Optic; Neuritis, With Demyelination
    Interventions:   Drug: CNM-Au8;   Drug: Placebo
    Sponsors:   Clene Nanomedicine;   Clene Australia Pty Ltd
    Recruiting

  • Conditions:   Macular Holes;   Epiretinal Membrane;   Diabetic Retinopathy;   Retinal Detachment;   Retinal Disease;   Preretinal Fibrosis;   Cataract;   Ocular Tumor;   Strabismus;   Healthy
    Intervention:   Device: Microscope integrated optical coherence tomography
    Sponsors:   Duke University;   National Eye Institute (NEI)
    Recruiting

  • Conditions:   Humoral Rejection;   Guillain-Barre Syndrome;   Miller Fisher Syndrome;   CIDP;   Good Pasture Syndrome;   Hyperviscosity Syndrome
    Interventions:   Drug: Fibrinogen concentrate;   Other: Fresh Frozen Plasma
    Sponsor:   University Medical Centre Ljubljana
    Recruiting

  • Conditions:   Thyroid Cancer;   Neck Cancer;   Recurrent Laryngeal Nerve Injuries;   Accessory Nerve Injuries;   EMG: Repetitive Nerve Stimulation Abnormality
    Intervention:   Drug: Lidocaine
    Sponsor:   Bo Wang,MD
    Recruiting

  • Conditions:   Acoustic Neuroma;   Labyrinthitis Ossificans;   Profound Hearing Impairment
    Intervention:   Device: MedEl Test Electrode Placer
    Sponsors:   Eric W. Sargent, MD;   Med-El Corporation
    Recruiting

  • Conditions:   Vocal Cord Paralysis Unilateral;   Dysphonia;   Dysphagia, Oropharyngeal
    Intervention:   Procedure: Silk Microparticle Filler Injection
    Sponsors:   University of Southern California;   Sofregen Medical, Inc.
    Not yet recruiting

  • Conditions:   Subcondylar Process of Mandible Open Fracture;   Facial Nerve Injuries
    Interventions:   Procedure: PRA approach;   Procedure: RT approach
    Sponsor:   Hani Taher Hibatullah Ali
    Not yet recruiting

  • Conditions:   Neurofibromatosis 2;   Dermatology/Skin - Other
    Intervention:   Other: no intervention
    Sponsor:   Centre Hospitalier Universitaire de Nice
    Recruiting

  • Condition:   Vestibular Vertigo
    Interventions:   Drug: Intranasal Drug;   Drug: Oral Tablet;   Other: Intranasal Placebo
    Sponsor:   Auris Medical AG
    Not yet recruiting

  • Conditions:   Progressive Supranuclear Palsy (PSP);   Corticobasal Degeneration (CBD);   Frontotemporal Dementia (FTD MAPT Mutation)
    Intervention:   Other: 13C6 Leucine
    Sponsors:   Washington University School of Medicine;   Association of Frontotemporal Degeneration;   Tau Consortium
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Hearing Loss
    Intervention:  
    Sponsor:   Christoph Arnoldner
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Hearing Loss
    Intervention:   Other: eABR
    Sponsor:   Christoph Arnoldner
    Recruiting

  • Conditions:   Brain Tumor, Recurrent;   Vestibular Schwannoma;   Brainstem Neoplasm;   Brainstem Glioma
    Intervention:   Procedure: Intraoperative Monitoring during resection of brain tumor
    Sponsor:   University Hospital Tuebingen
    Recruiting

  • Conditions:   Strabismus;   Reflex, Oculocardiac;   Hydroxyzine;   Bradycardia Sinus
    Interventions:   Drug: Midazolam;   Drug: Hydroxyzine Dihydrochloride
    Sponsor:   Yeditepe University
    Recruiting

  • Condition:   Vestibular Schwannoma
    Intervention:  
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting

  • Condition:   Patient Operated on From a Vestibular Schwannoma With a Middle Ear Exclusion
    Intervention:   Device: Robot Based Transtympanic drain placement
    Sponsor:   Assistance Publique - Hôpitaux de Paris
    Not yet recruiting

  • Conditions:   Vestibular Schwannoma;   Brain Metastases;   Para-optic Meningioma
    Intervention:   Device: Intuitive Plan
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Recruiting

  • Conditions:   Mild Traumatic Brain Injury;   Brain Concussion;   Convergence Insufficiency;   Accommodative Insufficiency;   Saccadic Eye Movement Deficiency;   Oculomotor Dysfunction
    Intervention:  
    Sponsor:   Minneapolis Medical Research Foundation
    Recruiting

  • Condition:   Unilateral Vocal Cord Paralysis
    Interventions:   Procedure: Acid hyaluronic injection laryngoplasty;   Behavioral: Voice therapy;   Other: Sham of injection;   Other: Sham of voice therapy
    Sponsor:   Cliniques universitaires Saint-Luc- Université Catholique de Louvain
    Not yet recruiting

  • Conditions:   Optic Neuritis;   Neuromyelitis Optica;   Multiple Sclerosis
    Intervention:   Diagnostic Test: Neuro-ophtalmology examination
    Sponsors:   University Hospital Center of Martinique;   University Hospital Center of Guadeloupe;   Hospital Center of Cayenne (French Guyana)
    Not yet recruiting

  • Conditions:   Mild Traumatic Brain Injury;   Vestibular Neuropathy
    Interventions:   Device: Incremental Velocity Error (IVE);   Behavioral: Traditional Vestibular Rehabilitation (VPT)
    Sponsors:   Johns Hopkins University;   Fort Belvoir Community Hospital;   Neuroscience Research Australia;   Walter Reed National Military Medical Center
    Not yet recruiting

  • Conditions:   Amblyopia;   Strabismus
    Intervention:   Device: Retinal Birefringence Imager
    Sponsors:   Rebiscan, Inc.;   Retina Foundation of the Southwest
    Not yet recruiting

  • Condition:   Vestibular Neuritis
    Interventions:   Other: Vestibular rehabilitation;   Drug: Corticosteroid
    Sponsor:   Aalborg Universitetshospital
    Recruiting

  • Conditions:   Neurofibromatosis Type 1;   Plexiform Neurofibroma;   Optic Nerve Glioma
    Intervention:   Drug: Selumetinib
    Sponsors:   Great Ormond Street Hospital for Children NHS Foundation Trust;   AstraZeneca
    Not yet recruiting

  • Condition:   Trigeminal Neuralgia (TN)
    Intervention:   Procedure: transcranial electrical brain stimulation
    Sponsors:   University of Florida;   Facial Pain Research Foundation
    Recruiting

  • Condition:   Bell Palsy
    Intervention:   Device: electrical stimulation device (tens unit)
    Sponsor:   Oregon Health and Science University
    Recruiting

  • Condition:   Vestibular Schwannoma
    Intervention:  
    Sponsor:   Haukeland University Hospital
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Intervention:   Drug: Fosphenytoin
    Sponsor:   Danish Headache Center
    Not yet recruiting

  • Condition:   Wolfram Syndrome
    Interventions:   Drug: Sodium Valproate 200Mg E/C Tablet;   Drug: Sodium Valproate matched placebo
    Sponsor:   University of Birmingham
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Intervention:   Other: telephone survey
    Sponsor:   University Hospital, Limoges
    Recruiting

  • Conditions:   Thyroidectomy;   Paralysis of Vocal Cords
    Intervention:   Diagnostic Test: Pre and postoperative ultrasound
    Sponsors:   Lille Catholic University;   University Hospital, Lille
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: BIIB074;   Drug: Placebo
    Sponsor:   Biogen
    Not yet recruiting

  • Condition:   Esthesioneuroblastoma, Olfactory
    Intervention:  
    Sponsor:   Ricardo L. Carrau, MD
    Recruiting

  • Conditions:   Dysphonia;   Unilateral Vocal Cord Paralysis
    Interventions:   Other: Standard of care voice therapy;   Device: Expiratory muscle strength training (EMST)
    Sponsor:   University of Miami
    Not yet recruiting

  • Conditions:   Corticobasal Syndrome;   Progressive Supranuclear Palsy;   Behavioral Variant Frontotemporal Dementia;   Semantic Dementia;   Progressive Nonfluent Aphasia;   Amyotrophic Lateral Sclerosis and/or Frontotemporal Dementia
    Intervention:   Other: Observational Study
    Sponsor:   University Health Network, Toronto
    Recruiting

  • Conditions:   Vocal Cord Paralysis;   Recurrent Laryngeal Nerve
    Intervention:   Drug: Group B. Sugammadex sodium-IONM
    Sponsor:   Lütfiye Nuri Burat Government Hospital
    Recruiting

  • Condition:   Strabismus
    Intervention:  
    Sponsor:   Second Affiliated Hospital, School of Medicine, Zhejiang University
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Other: EA+ Carbamazepine;   Other: EA+Placebo;   Other: sham EA+Carbamazepine;   Other: sham EA+Placebo
    Sponsors:   Zhejiang Chinese Medical University;   Jiaxing TCM Hospital
    Not yet recruiting

  • Conditions:   Emergence Delirium;   Strabismus
    Intervention:   Drug: Methadone
    Sponsor:   Ochsner Health System
    Recruiting

  • Condition:   Facial Paralysis
    Intervention:   Behavioral: Mindfulness Meditation Phone Application
    Sponsor:   Johns Hopkins University
    Not yet recruiting

  • Condition:   Facial Palsy
    Intervention:   Other: Records
    Sponsor:   Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil
    Recruiting

  • Conditions:   Bell Palsy;   Idiopathic Facial Paralyses
    Interventions:   Other: Laser acupuncture therapy;   Other: Sham laser acupuncture therapy
    Sponsor:   China Medical University Hospital
    Recruiting

  • Conditions:   Peripheral Facial Paralysis;   Quality of Life
    Interventions:   Other: Facial disability Index" (FDi);   Other: "Facial Clinimetric Evaluation" (FaCE)
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Recruiting

  • Condition:   Progressive Supranuclear Palsy
    Intervention:   Other: PSP-QoL
    Sponsor:   Assistance Publique Hopitaux De Marseille
    Not yet recruiting

  • Conditions:   Neurofibromatosis 2;   Vestibular Schwannoma;   Meningioma;   Ependymoma;   Glioma
    Intervention:   Drug: Selumetinib
    Sponsors:   Children's Hospital Medical Center, Cincinnati;   AstraZeneca
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Acoustic Neuroma;   Neurofibromatosis 2
    Interventions:   Drug: Aspirin;   Drug: Placebo
    Sponsors:   Massachusetts Eye and Ear Infirmary;   United States Department of Defense;   Massachusetts General Hospital
    Recruiting

  • Condition:   Recurrent Paralysis of Vocal Cords
    Interventions:   Drug: Corticoids;   Other: Placebo
    Sponsor:   Poitiers University Hospital
    Recruiting

  • Conditions:   Bell's Palsy;   Facial Nerve Paresis
    Interventions:   Procedure: Intratympanic injection;   Drug: Prednisone
    Sponsor:   University of Missouri-Columbia
    Recruiting

  • Condition:   Facial Nerve Paralysis
    Intervention:  
    Sponsor:   Assiut University
    Recruiting

  • Conditions:   Optic Neuritis;   Multiple Sclerosis;   Clinically Isolated Syndrome
    Intervention:   Other: Gluten-free diet
    Sponsors:   University of Copenhagen;   Rigshospitalet, Denmark
    Recruiting

  • Condition:   Acoustic Neuroma
    Intervention:   Other: Testing of Pre-Positioning Frame
    Sponsors:   Vanderbilt University Medical Center;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Not yet recruiting

  • Condition:   Vestibular Neuritis
    Intervention:  
    Sponsor:   University Hospital, Strasbourg, France
    Recruiting

  • Condition:   Bell Palsy
    Interventions:   Drug: Oral Corticosteroids;   Drug: Oral antivirals;   Device: Hyperbaric Oxygen Therapy
    Sponsor:   New York University School of Medicine
    Not yet recruiting

  • Conditions:   Hearing Loss, Cochlear;   Neurinoma of the Acoustic Nerve
    Interventions:   Device: Neuristim;   Device: Cochlear implant
    Sponsor:   Oticon Medical
    Recruiting

  • Conditions:   Multiple Sclerosis, Relapsing-Remitting;   Optic Neuritis
    Interventions:   Device: Dynamic Vessel Analyzer (DVA);   Device: Fourier Domain Doppler Optical Coherence Tomography (FDOCT);   Device: Optical coherence tomography (OCT)
    Sponsor:   Medical University of Vienna
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Intervention:   Drug: Oxtellar XR 150Mg Extended Release Tablet
    Sponsor:   University of Colorado, Denver
    Not yet recruiting

  • Conditions:   Corticobasal Degeneration (CBD);   Corticobasal Syndrome (CBS);   Cortical-basal Ganglionic Degeneration (CBGD);   Progressive Supranuclear Palsy (PSP);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
    Intervention:   Other: Observational Study
    Sponsors:   University of California, San Francisco;   National Institutes of Health (NIH);   National Institute on Aging (NIA)
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: Botulinum Toxin type A (intradermal / submucosal injection at pain area);   Drug: Botulinum Toxin type A (intra-masseter injection on the ipsilateral of pain involved)
    Sponsor:   The First Affiliated Hospital of Zhengzhou University
    Recruiting

  • Condition:   Progressive Supranuclear Palsy (PSP)
    Intervention:   Drug: ABBV-8E12
    Sponsor:   AbbVie
    Recruiting

  • Conditions:   Cafe Au Lait Spot;   Cutaneous Neurofibroma;   Dysplasia;   Lisch Nodule;   Neurofibromatosis Type 1;   NF1 Gene Mutation;   Optic Nerve Glioma
    Interventions:   Other: Laboratory Biomarker Analysis;   Drug: Selumetinib
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Brain Stem Neoplasm;   Pineal Region Neoplasm;   Recurrent Central Nervous System Neoplasm;   Recurrent Lymphoma;   Recurrent Malignant Solid Neoplasm;   Recurrent Visual Pathway Glioma;   Refractory Central Nervous System Neoplasm;   Refractory Lymphoma;   Refractory Malignant Solid Neoplasm;   Refractory Visual Pathway Glioma
    Interventions:   Drug: Entinostat;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Idiopathic Trigeminal Neuralgia
    Interventions:   Device: High-voltage pulsed radiofrequency;   Drug: Nerve block
    Sponsors:   Beijing Tiantan Hospital;   Beijing Friendship Hospital;   Beijing Ditan Hospital
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Drug: BIIB074;   Drug: Placebo
    Sponsor:   Biogen
    Not yet recruiting

  • Conditions:   Cluster Headache;   Cluster Headaches and Other Trigeminal Autonomic Cephalgias;   Paroxysmal Hemicrania;   SUNCT;   Hemicrania Continua;   Trigeminal Neuralgia
    Intervention:  
    Sponsor:   The University of Texas Health Science Center, Houston
    Recruiting

  • Conditions:   Orofacial Pain;   Trigeminal Neuralgia
    Intervention:   Other: occlusal adjustment
    Sponsor:   Meiqing Wang
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
    Intervention:   Drug: dantrolene sodium
    Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Deafness;   Diabetes Insipidus;   Ataxia
    Intervention:  
    Sponsors:   Washington University School of Medicine;   American Diabetes Association;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Glioma;   Pilocytic Astrocytoma;   Anaplastic Astrocytoma;   Glioblastoma;   Mixed Oligoastrocytoma;   Mixed Glioma;   Oligodendroglioma;   Optic Glioma;   Astrocytoma
    Interventions:   Device: MRI-guided laser ablation;   Drug: Doxorubicin;   Drug: Etoposide;   Device: Dynamic contrast-enhanced (DCE) MRI;   Device: Dynamic susceptibility contrast (DSC) MRI
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Condition:   Trigeminal Neuralgia
    Interventions:   Device: Unframed Virtual Cone;   Radiation: 80 Gy Radiation
    Sponsor:   University of Alabama at Birmingham
    Recruiting

  • Conditions:   Juvenile Pilocytic Astrocytomas;   Optic Pathway Gliomas
    Intervention:   Drug: Pegylated interferon alpha-2b
    Sponsors:   Emory University;   CURE Childhood Cancer, Inc.
    Recruiting

  • Conditions:   Dizziness;   Vertigo;   Vestibular Neuritis
    Interventions:   Behavioral: BI + VR + CBT;   Behavioral: BI + phone calls
    Sponsors:   Bergen University College;   University of Bergen;   Norwegian Fund for Postgraduate Training in Physiotherapy;   University of Southern Denmark;   Duke University;   Haukeland University Hospital
    Recruiting

  • Condition:   Progressive Supranuclear Palsy
    Intervention:   Drug: F-18 AV 1451
    Sponsor:   Mayo Clinic
    Recruiting

  • Conditions:   Lambert-Eaton Myasthenic Syndrome;   Congenital Myasthenic Syndrome;   Downbeat Nystagmus
    Intervention:   Drug: Amifampridine Phosphate
    Sponsor:   Catalyst Pharmaceuticals, Inc.
    Available

  • Conditions:   Opsoclonus Myoclonus Syndrome;   Neuroblastoma
    Interventions:   Drug: Dexamethasone acetate;   Drug: dexamethasone and cyclophosphamide;   Drug: dexamethasone and rituximab
    Sponsor:   Institut Curie
    Recruiting

  • Conditions:   Multiple Sclerosis;   Neuromyelitis Optica
    Intervention:   Biological: Tolerogenic Dendritic cells loaded with myelin peptides
    Sponsor:   Sara Varea
    Recruiting

  • Conditions:   Neurofibromatosis 1;   Neurofibromatosis 2;   Schwannomatosis
    Intervention:  
    Sponsor:   The Children's Tumor Foundation
    Recruiting

  • Conditions:   Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma;   Brainstem Glioma
    Interventions:   Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
    Sponsors:   Julie Krystal;   Janssen Pharmaceuticals
    Recruiting

  • Condition:   Multiple Sclerosis
    Interventions:   Drug: ACTHAR Gel (ACTH);   Drug: IV methylprednisolone (steroids)
    Sponsors:   University of Colorado, Denver;   Mallinckrodt;   University of Pennsylvania
    Recruiting

  • Conditions:   Adenoid Cystic Carcinoma;   Squamous Cell Carcinoma;   Sinonasal Carcinoma;   Sinonasal Undifferentiated Carcinoma;   Mucoepidermoid Carcinoma;   Schneiderian Carcinoma;   Myoepithelial Carcinoma;   Esthesioneuroblastoma;   Melanoma
    Interventions:   Radiation: Proton radiation therapy;   Radiation: Intensity-modulated radiotherapy
    Sponsors:   Massachusetts General Hospital;   National Institutes of Health (NIH);   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Vestibular Schwannoma;   Acoustic Neuroma
    Intervention:   Radiation: Fractionated proton radiation
    Sponsors:   Massachusetts General Hospital;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome;   Ciliopathy
    Intervention:  
    Sponsor:   National Human Genome Research Institute (NHGRI)
    Recruiting

  • Conditions:   Low Grade Glioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Neurofibromatosis Type 1;   Recurrent Visual Pathway Glioma;   Refractory Neurofibromatosis Type 1;   Refractory Visual Pathway Glioma
    Interventions:   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Selumetinib
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Neurofibromatosis Type 1;   Malignant Peripheral Nerve Sheath Tumor;   Plexiform Neurofibroma;   Optic Glioma;   Neurofibroma
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting